One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Avonib is a type 1 isocitrate dehydrogenase (IDH1) inhibitor that specifically inhibits the mutant form of IDH1 in the cytoplasm, preventing the formation of 2-hydroxyglutarate. AG-120 can induce cell differentiation and inhibit the proliferation of tumor cells expressing IDH1.